Maxwell G M
Br J Pharmacol. 1973 Oct;49(2):370-2. doi: 10.1111/j.1476-5381.1973.tb08387.x.
AH5158, a salicylamide derivative, said to be a blocker of alpha- and beta-adrenoceptors, has been studied in intact anaesthetized dogs. At a dose of 2.5 mg/kg intravenously, the drug increased cardiac output and caused a late fall in mean systemic and pulmonary arterial pressure. Coronary sinus flow increased, as did cardiac oxygen extraction. External cardiac efficiency decreased. Blood glucose and non-esterified fatty acid values increased, but cardiac extraction of these did not change.
AH5158是一种水杨酰胺衍生物,据说它是α和β肾上腺素能受体阻滞剂,已在完整的麻醉犬身上进行了研究。静脉注射剂量为2.5毫克/千克时,该药物增加了心输出量,并导致平均体循环和肺动脉压后期下降。冠状窦血流量增加,心脏氧摄取量也增加。心脏外部效率降低。血糖和非酯化脂肪酸值升高,但心脏对这些物质的摄取没有变化。